Leading UK labs to collaborate on commercial healthcare offerings
The ISIS Neutron and Muon Source at the STFC Rutherford Appleton Laboratory, near Oxford, and the National Physical Laboratory (NPL), Teddington, have agreed to develop closer business and research links to collaborate on commercial offerings for the healthcare industry.
ISIS produces beams of neutrons allowing scientists to study materials at the atomic and molecular level. Neutron scattering is an established technique providing unique insight into atomic structures and molecular interactions by measuring the locations of atoms and the forces between them. This technique has proved particularly useful for the healthcare sector, providing pioneering insight into drug research, cell and membrane interactions and surgical implants.
Andrew Taylor, Executive Director for National Laboratories at STFC (Science and Technology Facilities Council), said:
"This partnership will seek to make closer connections between the two laboratories, to enhance the application of neutron scattering research by industry and to solve end-user problems in real-world environments."
Keith Dobson, Head of Business Development at NPL, said:
"We will draw on NPL's multi-disciplinary approach to research and the broad experience in using neutron scattering for materials research at ISIS to provide new insight into medical technologies."
NPL's healthcare research focuses across diagnostics, medical physics and health and wellbeing where measurement plays a vital role in ensuring reliable and robust detection diagnosis and treatment. As diagnosis of disease, long-term patient care and wellness monitoring becomes more personalised, therapies and technologies for diagnosis and treatment need more reliable, safe and cost-effective measurements.
ISIS has strong links with industry and universities and supports some 3,000 scientists using neutrons for a wide range of research including clean energy and the environment, bioscience, pharmaceuticals and health care, nanotechnology, materials engineering and IT.
ISIS is free to use provided research results are published into the public domain. Where commercial confidentiality is important, companies can join the fast-track ISIS Collaborative R&D Programme giving full control over intellectual property.
Find out more about ISIS
Examples of NPL's Healthcare research:
- NPL scientists improve biomarker detection technique
- Ultrasound screening for breast cancer
- NPL spin out - Argento Diagnostics
Read the Healthcare edition of Insights - Beyond measurement
More on NPL's work in Healthcare